Latest Breaking News On - Cerevel therapeutics holdings - Page 7 : comparemela.com

Calamos Advisors LLC Makes New Investment in Cerevel Therapeutics Holdings, Inc (NASDAQ:CERE)

Calamos Advisors LLC purchased a new position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 305,303 shares of the biotechnology company’s stock, valued at approximately $12,945,000. Calamos Advisors LLC owned 0.17% of Cerevel […]

United statesN anthony colesJohn rengerTower research capitalCentaurus financial incJefferies financial groupRoyal bankFinancial services group incAmeritas investment partners incJpmorgan chase coCerevel therapeutics holdings incCalamos advisorsCerevel therapeutics company profileCerevel therapeutics holdingsFree reportCerevel therapeutics

Arizona State Retirement System Has $840,000 Holdings in Cerevel Therapeutics Holdings, Inc (NASDAQ:CERE)

Arizona State Retirement System grew its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 10.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,816 shares of the biotechnology company’s stock after buying an additional 1,954 shares during the quarter. Arizona State […]

United statesJohn rengerN anthony colesJefferies financial groupAmeritas investment partners incFinancial services group incJpmorgan chase coCerevel therapeutics holdings incRoyal bankTower research capitalCentaurus financial incSecurities exchange commissionArizona state retirement systemCerevel therapeutics holdingsFree reportState retirement system

Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson s Disease Study

Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson s Disease Study
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cerevel therapeutics holdings incCerevel therapeutics holdings

Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday? - Landos Biopharma (NASDAQ:LABP)

AbbVie seals deal with Landos Biopharma at $20.42/share, totaling $137.5 million plus CVR. Acquisition targets NX-13, promising oral treatment for ulcerative colitis & Crohn's disease.

United statesRoopal thakkarLandos biopharma incCerevel therapeutics holdings incAbbvie incCerevel therapeutics holdings

Avidity Partners Management LP Buys 141,800 Shares of Cerevel Therapeutics Holdings, Inc (NASDAQ:CERE)

Avidity Partners Management LP raised its holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 28.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 643,000 shares of the biotechnology company’s stock after purchasing an additional 141,800 shares during the quarter. […]

United statesRamiro sanchezScott akamineTower research capitalJefferies financial groupJpmorgan chase coSecurities exchange commissionCentaurus financial incCerevel therapeutics holdings incRoyal bankExchange commissionAmeritas investment partners incFinancial services group incAvidity partners managementCerevel therapeutics holdingsFree report